Search Results

• • 11 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• [.sup.18]F-Fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) is accurate for high-grade prostate cancer bone staging when compared to bone scintigraphy.

  Authors:Samuel Otis-Chapados, Cassandra Ringuette Goulet, Gabriel Dubois, Etienne Lavallee, Thierry Dujardin, Yves Fradet, et al.From:Canadian Urological Association Journal (Vol. 15, Issue 10) Peer-Reviewed

  Oct. 20214,009 words Report 1500LIntroduction: In this study, we compared [.sup.18]F-FDG-postron emission tomography/computed tomography (PET/CT) and bone scintigraphy accuracies for the detection of bone metastases for primary staging in high-grade...

• Switching from a gonadotropin-releasing hormone (GnRH) agonist to a GnRH antagonist in prostate cancer patients: A systematic review and meta-analysis.

  Authors:Kaleem S. Atchia, Christopher J.D. Wallis, Neil Fleshner, and Paul TorenFrom:Canadian Urological Association Journal (Vol. 14, Issue 2) Peer-Reviewed

  Feb. 20203,696 words Article 1580LIntroduction: We sought to address whether there are clinical responses when patients who are failing gonadotropin-releasing hormone (GnRH) agonist therapy are switched to degarelix. Androgen-deprivation therapy remains...

• Combined AKT and MEK Pathway Blockade in Pre-Clinical Models of Enzalutamide-Resistant Prostate Cancer

  Authors:Paul Toren, Soojin Kim, Fraser Johnson, and Amina ZoubeidiFrom:PLoS ONE (Vol. 11, Issue 4) Peer-Reviewed

  Apr. 5, 20166,543 words Report 1450LDespite recent improvements in patient outcomes using newer androgen receptor (AR) pathway inhibitors, treatment resistance in castrate resistant prostate cancer (CRPC) continues to remain a clinical problem....

• Exercise effects on adipokines and the IGF axis in men with prostate cancer treated with androgen deprivation: A randomized study

  Authors:Daniel Santa Mina, Michael K. Connor, Shabbir M.H. Alibhai, Paul Toren, Crissa Guglietti, Andrew G. Matthew, et al.From:Canadian Urological Association Journal (Vol. 7, Issue 11-12) Peer-Reviewed

  November-December 20133,895 words Report 1670LAuthor(s): Daniel Santa Mina, PhD (corresponding author), Michael K. Connor, PhD, Shabbir M.H. Alibhai, MD, Paul Toren, MD, Crissa Guglietti, PhD, Andrew G. Matthew, PhD, John Trachtenberg, MD, Paul Ritvo, PhD...

• Building a Canadian Translational Bladder Cancer Research Network

  Authors:Madhuri Koti, David M. Berman, D. Robert Siemens, Dirk Lange, Edwin Wang, Paul Toren, et al.From:Canadian Urological Association Journal (Vol. 14, Issue 10) Peer-Reviewed

  Oct. 20203,095 words Report 1510LIntroduction Bladder cancer is poised to join the precision oncology pantheon, presenting a broad array of exciting research avenues to improve current therapeutic management and patient quality of life. Emerging...

• A prospective, multisite study analyzing the percentage of urological cases that can be completely managed by telemeaicine

  Authors:Bruno Turcotte, Sophie Paquet, Anne-Sophie Blais, Annie-Claude Blouin, Stephane Bolduc, Michel Bureau, et al.From:Canadian Urological Association Journal (Vol. 14, Issue 10) Peer-Reviewed

  Oct. 20201,680 words Report 1560LIntroduction: The COVID-19 pandemic has accelerated the development of telemedicine due to confinement measures. However, the percentage of outpatient urological cases that could be managed completely by telemedicine...

• Images--Para-aortic lymphatic ectasia suggestive of testicular cancer retroperitoneal metastasis.

  Authors:Sonia Chahine and Paul TorenFrom:Canadian Urological Association Journal (Vol. 15, Issue 1) Peer-Reviewed

  Jan. 20211,383 words Clinical report 1560LIntroduction Para-aortic lymphatic ectasia is an anatomic variant that can be confused with metastatic lymph nodes. To date, there are few reports of this in the literature. It appears this variant is rare, but the...

• Rational cotargeting of Pim-1 and Akt in prostate cancer

  Authors:Paul Toren and Amina ZoubeidiFrom:Expert Review of Anticancer Therapy (Vol. 13, Issue 8) Peer-Reviewed

  Aug. 20132,275 words Clinical report 1490LAuthor(s): Paul Toren 1 , Amina Zoubeidi [*] 2 Keywords : Akt; cap-independent translation; Pim-1; RTK; resistance Deletion or mutation of PTEN is one of the hallmarks of prostate cancer which has led to...

• Use of a novel parenchymal clamp for laparoscopic and open partial nephrectomy

  Authors:Paul Toren, Turki Al-Essawi, Anthony Mclean, and Umesh JainFrom:Canadian Urological Association Journal (Vol. 4, Issue 5) Peer-Reviewed

  Oct. 1, 2010 Case study

   Citation Only

• The effect of nerve-sparing surgery on patient-reported continence post-radical prostatectomy

  Authors:Paul Toren, Shabbir M.H. Alibhai, Andre Matthew, Michael Nesbitt, Robin Kalnin, Neil Fleshner, et al.From:Canadian Urological Association Journal (Vol. 3, Issue 6) Peer-Reviewed

  Dec. 20092,650 words Report 1570LAuthor(s): Paul Toren, MD [1], Shabbir M.H. Alibhai, MD, MSc [2,3,4], Andre Matthew, PhD [5], Michael Nesbitt [5], Robin Kalnin, BMus, Neil Fleshner, MD, FRCSC [1,5], John Trachtenberg, MD, FRCSC (corresponding author)...

• Effect of dutasteride on clinical progression of benign prostatic hyperplasia in asymptomatic men with enlarged prostate: a post hoc analysis of the REDUCE study

  Authors:Paul Toren, Alexandre Zlotta, Antonio Finelli, Girish Kulkarni, Neil Fleshner, and David MargelFrom:British Medical Journal (Vol. 346, Issue 7908) Peer-Reviewed

  May 18, 201338 words Clinical report

   Citation Only